Spearheading End-to-End LNP Development by Leveraging Novel Lipids, Incorporating Automation & Improving Reliability of LNP Analytics to Accelerate LNPs from Research to Market
The 5th Lipid Nanoparticles Development Summit Europe returns to Berlin at a pivotal moment for the field, as LNPs move beyond COVID-19 vaccines into broader therapeutic applications including gene editing, oncology, and in vivo cell therapy. This meeting brings together leading biotech, pharma and academic experts to tackle the biggest barriers preventing LNPs from reaching their full clinical potential.
What sets this event apart is its end-to-end focus, covering everything from early design and intracellular delivery, through analytical and CMC strategy, to regulatory alignment and scalable manufacturing. Unlike traditional meetings, it goes beyond well-known challenges to spotlight next-generation innovations, including extrahepatic targeting, hybrid nanoparticle systems, and strategies for repeat dosing and reduced toxicity.
The timing couldn’t be more critical. As the industry faces increasing scrutiny around safety, delivery precision and commercial viability, there is a growing need to align innovation with real-world application and regulatory expectations. This summit provides a unique platform to do exactly that, through expert-led sessions, interactive debates, and practical case studies.
For anyone serious about advancing LNP-based therapeutics, this is the forum to gain clarity, challenge assumptions and accelerate progress.
The event was well distributed between research talks, company talks and moments for networking.
Analytical Development Scientist, BSP Pharmaceuticals
The meeting offers the opportunity to keep on top of the latest developments on the LNP space and network with both industrial and academic experts in the field.
CEO, Sisaf
Cutting-edge presentations.
Formulation Scientist, Daiichi Sankyo
Explore the Full Event Guide
- Get a clear, at-a-glance view of the full agenda, themes and speaker line-up
- Identify the sessions most relevant to your work and key LNP challenges
- Explore how leading companies are tackling delivery, targeting and scalability
- Discover interactive sessions, debates and networking opportunities
- Easily share with colleagues to align on attendance and priorities
Book Your Free 1:1 Agenda Consultation
Connect with our dedicated team member to review the agenda, explore the speakers, and identify the sessions most relevant to your role and company.
Fatima Farooq
Delegate Audience Manager
Official Partners
Attending Companies Include:
Explore the Agenda
Dive into cutting-edge LNP innovation across targeting, delivery, CMC and clinical translation through expert-led talks, interactive debates and practical case studies.
Partner With Us
Position your solutions at the forefront of LNP development and connect with biotech and pharma leaders actively advancing next-generation RNA and gene therapies.
Join LNP Leaders
Engage with a highly focused community of LNP experts across discovery, formulation and manufacturing, and build meaningful connections during dedicated networking sessions.